pmc logo image
Logo of jcinvestCurrent issueArchiveSubscribe to the JCIAbout the JCIThe Journal of Clinical Investigation

Formats:

J Clin Invest. 1989 April; 83(4): 1153–1159.
doi: 10.1172/JCI113995.
PMCID: PMC303801
Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells.
A Barchowsky, K Tabrizi, R S Kent, and A R Whorton
Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710.
Abstract
We have examined the effects of menadione on porcine aortic endothelial cell prostaglandin synthesis. Addition of 1-20 microM menadione caused a dose- and time-dependent inhibition of stimulated prostaglandin synthesis with an IC50 of 5 microM at 15 min. Concentrations greater than 100 microM menadione were necessary to increase 51Cr release from prelabeled cells. Recovery of enzyme inactivated by menadione required a 6-h incubation in 1% serum. In a microsomal preparation, menadione was shown to have no direct effect on conversion of arachidonic acid to prostaglandins. In intact cells menadione caused only a 40% inhibition of the conversion of PGH2 to prostacyclin. Enzymes involved in the incorporation and the release of arachidonic acid were not affected by menadione (20 microM, 15 min). Menadione undergoes oxidation/reduction reactions in intact cells leading to partial reduction of oxygen-forming, reactive oxygen species. In our cells menadione was found to increase KCN-resistant oxygen consumption. Further, an increased accumulation of H2O2 was observed with a time course consistent with menadione-induced inhibition of prostaglandin synthesis. We conclude that menadione at sublethal doses caused inhibition of prostaglandin synthesis. The mechanism involves inactivation of PGH2 synthase by a reactive species resulting from metabolism of menadione by endothelial cells.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Suttorp N, Simon LM. Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest. 1982 Aug;70(2):342–350. [PubMed]
  • Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. [PubMed]
  • Autor AP, Bonham AC, Thies RL. Toxicity of oxygen radicals in cultured pulmonary endothelial cells. J Toxicol Environ Health. 1984;13(2-3):387–395. [PubMed]
  • Sjostrom K, Crapo JD. Structural and biochemical adaptive changes in rat lungs after exposure to hypoxia. Lab Invest. 1983 Jan;48(1):68–79. [PubMed]
  • Orr FW, Warner DJ. Effects of neutrophil-mediated pulmonary endothelial injury on the localization and metastasis of circulating Walker carcinosarcoma cells. Invasion Metastasis. 1987;7(3):183–196. [PubMed]
  • Reidy MA, Schwartz SM. Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium. Lab Invest. 1983 Jan;48(1):25–34. [PubMed]
  • Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed]
  • Lazo JS. Endothelial injury caused by antineoplastic agents. Biochem Pharmacol. 1986 Jun 15;35(12):1919–1923. [PubMed]
  • Adamson IY. Drug-induced pulmonary fibrosis. Environ Health Perspect. 1984 Apr;55:25–36. [PubMed]
  • Whorton AR, Montgomery ME, Kent RS. Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells. J Clin Invest. 1985 Jul;76(1):295–302. [PubMed]
  • Barchowsky A, Kent RS, Whorton AR. Recovery of porcine aortic endothelial cell prostaglandin synthesis following inhibition by sublethal concentrations of hydrogen peroxide. Biochim Biophys Acta. 1987 Mar 11;927(3):372–381. [PubMed]
  • Gryglewski RJ, Moncada S. Secretory function of vascular endothelium. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:397–404. [PubMed]
  • Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med. 1987 Jul;110(1):13–30. [PubMed]
  • Czervionke RL, Smith JB, Fry GL, Hoak JC, Haycraft DL. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest. 1979 May;63(5):1089–1092. [PubMed]
  • Fantone JC, Kinnes DA. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun. 1983 Jun 15;113(2):506–512. [PubMed]
  • Kulmacz RJ. Prostaglandin H synthase and hydroperoxides: peroxidase reaction and inactivation kinetics. Arch Biochem Biophys. 1986 Sep;249(2):273–285. [PubMed]
  • Marshall PJ, Kulmacz RJ, Lands WE. Constraints on prostaglandin biosynthesis in tissues. J Biol Chem. 1987 Mar 15;262(8):3510–3517. [PubMed]
  • Kent RS, Diedrich SL, Whorton AR. Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta. J Clin Invest. 1983 Aug;72(2):455–465. [PubMed]
  • Brotherton AF, Hoak JC. Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase. J Clin Invest. 1983 Oct;72(4):1255–1261. [PubMed]
  • Madden MC, Eling TE, Friedman M. Ozone inhibits endothelial cell cyclooxygenase activity through formation of hydrogen peroxide. Prostaglandins. 1987 Sep;34(3):445–463. [PubMed]
  • Thor H, Smith MT, Hartzell P, Bellomo G, Jewell SA, Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J Biol Chem. 1982 Oct 25;257(20):12419–12425. [PubMed]
  • de Groot H, Noll T, Sies H. Oxygen dependence and subcellular partitioning of hepatic menadione-mediated oxygen uptake. Studies with isolated hepatocytes, mitochondria, and microsomes from rat liver in an oxystat system. Arch Biochem Biophys. 1985 Dec;243(2):556–562. [PubMed]
  • Jones TW, Thor H, Orrenius S. Cellular defense mechanisms against toxic substances. Arch Toxicol Suppl. 1986;9:259–271. [PubMed]
  • Frei B, Winterhalter KH, Richter C. Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria. Biochemistry. 1986 Jul 29;25(15):4438–4443. [PubMed]
  • Rosen GM, Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7269–7273. [PubMed]
  • Whorton AR, Young SL, Data JL, Barchowsky A, Kent RS. Mechanism of bradykinin-stimulated prostacyclin synthesis in porcine aortic endothelial cells. Biochim Biophys Acta. 1982 Jul 20;712(1):79–87. [PubMed]
  • Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur J Biochem. 1972 Feb;25(3):420–430. [PubMed]
  • BERGMEYER HU. Zur Messung von Katalase-Aktivitäten. Biochem Z. 1955;327(4):255–258. [PubMed]
  • McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969 Nov 25;244(22):6049–6055. [PubMed]
  • Thayer WS. Adriamycin stimulated superoxide formation in submitochondrial particles. Chem Biol Interact. 1977 Dec;19(3):265–278. [PubMed]
  • Hassan HM, Fridovich I. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch Biochem Biophys. 1979 Sep;196(2):385–395. [PubMed]
  • Salmon JA, Smith DR, Flower RJ, Moncada S, Vane JR. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochim Biophys Acta. 1978 Mar 14;523(1):250–262. [PubMed]
  • Nolan RD, Eling TE. Inhibition of prostacyclin synthesis in cultured bovine aortic endothelial cells by vitamin K1. Biochem Pharmacol. 1986 Dec 1;35(23):4273–4281. [PubMed]
  • Dobrina A, Rossi F. Metabolic properties of freshly isolated bovine endothelial cells. Biochim Biophys Acta. 1983 Apr 5;762(2):295–301. [PubMed]
  • Bellomo G, Mirabelli F, DiMonte D, Richelmi P, Thor H, Orrenius C, Orrenius S. Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem Pharmacol. 1987 Apr 15;36(8):1313–1320. [PubMed]
  • Chlebowski RT, Akman SA, Block JB. Vitamin K in the treatment of cancer. Cancer Treat Rev. 1985 Mar;12(1):49–63. [PubMed]
  • Su YZ, Duarte TE, Dill PL, Weisenthal LM. Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms. Cancer Treat Rep. 1987 Jun;71(6):619–625. [PubMed]
  • Di Monte D, Bellomo G, Thor H, Nicotera P, Orrenius S. Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis. Arch Biochem Biophys. 1984 Dec;235(2):343–350. [PubMed]
  • Talcott RE, Smith MT, Giannini DD. Inhibition of microsomal lipid peroxidation by naphthoquinones: structure-activity relationships and possible mechanisms of action. Arch Biochem Biophys. 1985 Aug 15;241(1):88–94. [PubMed]
  • Younes M, Cornelius S, Siegers CP. Fe2+-supported in vivo lipid peroxidation induced by compounds undergoing redox cycling. Chem Biol Interact. 1985 Jun;54(1):97–103. [PubMed]